Evidence map›Paper›PMID 40043423›Full record

ArticleOral oncology2025

Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas.

Hanna M Hieromnimon, Anna Trzcinska, Frank T Wen, Frederick M Howard, James M Dolezal, Emma Dyer, Sara Kochanny, Jefree J Schulte, Cindy Wang, Heather Chen and 14 more

Erratum issuedAbstract read
In one paragraph

Article in Oral oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Hanna M HieromnimonGraduate Program in Biophysical Sciences, University of Chicago, Chicago, IL 60637, USA.
Anna TrzcinskaDepartment of Pathology, University of Chicago, Chicago, IL 60637, USA.
Frank T WenDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA.
Frederick M HowardDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA.
James M DolezalGeisinger Cancer Institute, Danville PA 17822, USA.
Emma DyerDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA.
Sara KochannyDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA.
Jefree J SchulteDepartment of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI 53792, USA.
Cindy WangDepartment of Pathology, Stanford University, Palo Alto, CA 94305, USA.
Heather ChenDepartment of Pathology, University of Michigan, Ann Arbor, MI 48109, USA.
Jeffrey ChinDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA.
Elizabeth BlairDepartment of Surgery.
Nishant AgrawalDepartment of Surgery.
Ari RosenbergDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA.
Everett VokesDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA.
Rohan KatipallyDepartment of Radiation and Cellular Oncology.
Aditya JulooriDepartment of Radiation and Cellular Oncology.
Evgeny IzumchenkoDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA.
Mark W LingenDepartment of Pathology, University of Chicago, Chicago, IL 60637, USA; Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Nicole CiprianiDepartment of Pathology, University of Chicago, Chicago, IL 60637, USA.
Jalal B JalalyDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Devraj BasuDepartment of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA.
Samantha J RiesenfeldDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA; Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL 60637, USA; CZ Biohub Chicago, LLC, University of Chicago, Chicago, IL 60642, USA; NSF-Simons National Institute for Theory and Mathematics in Biology (NITMB), Chicago, IL 60637, USA. Electronic address: sriesenfeld@uchicago.edu.
Alexander T PearsonDepartment of Medicine, University of Chicago, Chicago, IL 60637, USA; CZ Biohub Chicago, LLC, University of Chicago, Chicago, IL 60642, USA. Electronic address: alexander.pearson@bsd.uchicago.edu.

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1M
BASIC RESEARCH TRAINING IN MEDICAL ONCOLOGYT32CA009566 · NCI · UNIVERSITY OF CHICAGO · PI OLUFUNMILAYO F. OLOPADE · 1987 to 2026
$10.5M
The Funding Mechanism of the Pilot TrialR01CA276652 · NCI · UNIVERSITY OF CHICAGO · PI Hiroyuki Abe, Gregory S. Karczmar · 2023 to 2026
$5.0M
Exploiting differences in HPV oncoprotein function among oropharyngeal cancers to personalize therapyR01DE034056 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI Devraj Basu · 2024 to 2026
$1.7M
PROSPECT: Premalignant Oral Lesions Pathology and Epigenetic Risk Prediction ToolR01CA293995 · NCI · LOMA LINDA UNIVERSITY · PI AOUIZERAT, BRADLEY E, PEARSON, ALEXANDER THOMAS · 2024 to 2025
$1.4M
Integrating Clinical, Pathologic, and Immune Features to Predict Breast Cancer Recurrence and Chemotherapy BenefitK08CA283261 · NCI · UNIVERSITY OF CHICAGO · PI Frederick Matthew Howard · 2023 to 2026
$806k
Pursuing molecular biomarkers to guide adjuvant therapy for HPV+ head and neck cancers after transoral robotic surgeryUH2CA267502 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BASU, DEVRAJ · 2022 to 2023
$415k
Deep learning for oral premalignancy evaluationR56DE030958 · NIDCR · UNIVERSITY OF CHICAGO · PI PEARSON, ALEXANDER THOMAS · 2021 to 2021
$331k
NCI NIH HHS K08 CA283261NCI NIH HHS P30 CA014599NCI NIH HHS R01 CA276652NCI NIH HHS R01 CA293995NCI NIH HHS T32 CA009566NCI NIH HHS UH2 CA267502NIDCR NIH HHS R01 DE034056NIDCR NIH HHS R56 DE030958
6 · The paper itself

Abstract

objectivesHuman papillomavirus (HPV) influences the pathobiology of Head and Neck Squamous Cell Carcinomas (HSNCCs). While deep learning shows promise in detecting HPV from hematoxylin and eosin (H&E) stained slides, the histologic features utilized remain unclear. This study leverages artificial intelligence (AI) foundation models to characterize histopathologic features associated with HPV presence and objectively describe patterns of variability in the HPV-positive space. MATERIALS AND

methodsH&E images from 981 HNSCC patients across public and institutional datasets were analyzed. We used UNI, a foundation model based on self-supervised learning (SSL), to map the landscape of HNSCC histology and identify the axes of SSL features that best separate HPV-positive and HPV-negative tumors. To interpret the histologic features that vary across different regions of this landscape, we used HistoXGAN, a pretrained generative adversarial network (GAN), to generate synthetic histology images from SSL features, which a pathologist rigorously assessed.

resultsAnalyzing AI-generated synthetic images found distinctive features of HPV-positive histology, such as smaller, paler, more monomorphic nuclei; purpler, amphophilic cytoplasm; and indistinct cell borders with rounded tumor contours. The SSL feature axes we identified enabled accurate prediction of HPV status from histology, achieving validation sensitivity and specificity of 0.81 and 0.92, respectively. Our analysis subdivided image tiles from HPV-positive histology into three overlapping subtypes: border, inflamed, and stroma.

conclusionFoundation-model-derived synthetic pathology images effectively capture HPV-related histology. Our analysis identifies distinct subtypes within HPV-positive HNSCCs and enables accurate, explainable detection of HPV presence directly from histology, offering a valuable approach for low-resource clinical settings.

Indexed as

Artificial IntelligenceHead and Neck NeoplasmsPapillomavirus InfectionsSquamous Cell Carcinoma of Head and NeckFemaleHumansMalePapillomaviridaeHead and neck squamous cell carcinomaHistologyHuman papillomavirusSelf-supervised learning

Identifiers

PMID40043423
PMCPMC13403747

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.